
Quit 0.25mg Tablet
Marketer
Ind Swift Laboratories Ltd
Salt Composition
Alprazolam (0.25mg)
Overview Quit 0.25mg Tablet
0.25mg Quit tablets are classified as benzodiazepines, prescribed for anxiety management. They function by modifying brain activity, inducing calmness, and alleviating panic attacks through nerve relaxation. Quit 0.25mg tablets can be administered with or without food; however, consistent daily timing is recommended for optimal therapeutic blood levels. Adhere strictly to your physician's prescribed dosage and duration, as this medication carries a significant risk of dependence. Missed doses should be taken immediately upon recall, and the entire treatment course must be completed, irrespective of symptom improvement. Abrupt cessation is strongly discouraged; consult your doctor before discontinuing to avoid potential withdrawal symptoms such as nausea and anxiety. Drowsiness and lightheadedness are common side effects; avoid activities requiring alertness, like driving, until the medication's impact is known. Weight fluctuations (gain or loss) are possible and vary individually. A balanced diet, limiting high-calorie snacks, and regular exercise can help manage weight gain. Conversely, weight loss can be addressed by increasing food intake and seeking dietary advice from a registered dietitian. Long-term use may necessitate routine blood and liver function monitoring.
Uses of Quit 0.25mg Tablet
Managing Anxiety and Panic Disorders
Major Benefits of Quit 0.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The 0.25mg Quit tablet can be administered with or without food, though consistent timing is recommended.
Common Side effects of Quit 0.25mg Tablet:
- Lightheadedness
- Drowsiness
How to use Quit 0.25mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 0.25mg Quit tablet can be consumed with or without food, though consistent timing is recommended.
How Quit 0.25mg Tablet works:
0.25mg Quit Tablets contain a benzodiazepine that enhances the effects of GABA, a neurotransmitter. This action reduces heightened, irregular neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Quit 0.25mg Tablet and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Discontinuing use of 0.25mg Quit Tablets is advised during pregnancy due to confirmed risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Discontinuing use of 0.25mg Quit Tablets is advised while breastfeeding. Preliminary human research indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Discontinuation of 0.25mg tablets can reduce vigilance, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
The 0.25mg Quit Tablet is likely safe for individuals with kidney impairment. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Quit 0.25mg tablets. Dosage modification of Quit 0.25mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Quit 0.25mg Tablet :
Should you forget a Quit 0.25mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Quit 0.25mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzodiazepine Analogs |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience (Central Nervous System) |
| Behavioral Class | Benzodiazepine medications |
